We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+1.08%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$5.34B
AUM Growth
-$50.9M
Cap. Flow
-$52.9M
Cap. Flow %
-0.99%
Top 10 Hldgs %
21.31%
Holding
1,883
New
141
Increased
840
Reduced
630
Closed
218

Sector Composition

Rank Sector Weight
1 Industrials 4.45%
2 Consumer Staples 3.82%
3 Healthcare 3.8%
4 Financials 3.59%
5 Communication Services 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEN
1626
DELISTED
Genesis Healthcare, Inc.
GEN
$44K ﹤0.01%
+10,322
New +$34K
CRDF icon
1627
Cardiff Oncology
CRDF
$78.6M
$42K ﹤0.01%
276
+13
+5% +$3.04K
SEAC
1628
DELISTED
Seachange International Inc
SEAC
$42K ﹤0.01%
920
-25
-3% -$1.31K
REFR icon
1629
Research Frontiers
REFR
$17.1M
$41K ﹤0.01%
22,300
-500
-2% -$1.03K
IEC
1630
DELISTED
IEC Electronics Corp.
IEC
$39K ﹤0.01%
+10,853
New +$40.7K
MVIS icon
1631
Microvision
MVIS
$85.6M
$38K ﹤0.01%
2,008
XXII
1632
22nd Century Group
XXII
$1.46M
0
VNR
1633
DELISTED
Vanguard Natural Resources, LLC
VNR
$35K ﹤0.01%
52,352
-35,908
-41% -$26K
PRPO icon
1634
Precipio
PRPO
$40.7M
$32K ﹤0.01%
13
ORKA
1635
Oruka Therapeutics
ORKA
$6.2B
$30K ﹤0.01%
48
CRNT icon
1636
Ceragon Networks
CRNT
$201M
$28K ﹤0.01%
10,735
-1,000
-9% -$2.4K
TLPH icon
1637
Talphera
TLPH
$73.7M
$27K ﹤0.01%
515
ACGN
1638
DELISTED
Aceragen Inc
ACGN
$27K ﹤0.01%
132
NVCN
1639
DELISTED
Neovasc Inc.
NVCN
$27K ﹤0.01%
+1
New +$24K
PGH
1640
DELISTED
Pengrowth Energy Corporation
PGH
$27K ﹤0.01%
18,784
-426
-2% -$654
QMCO icon
1641
Quantum Corp
QMCO
$705M
$26K ﹤0.01%
193
ASXC
1642
DELISTED
Asensus Surgical, Inc.
ASXC
$26K ﹤0.01%
1,531
+539
+54% +$11K
PLM
1643
DELISTED
PolyMet Mining Corp.
PLM
$25K ﹤0.01%
3,419
ZN
1644
DELISTED
Zion Oil & Gas, Inc.
ZN
$24K ﹤0.01%
17,251
HEPA
1645
DELISTED
Hepion Pharmaceuticals
HEPA
0
EGY icon
1646
Vaalco Energy
EGY
$616M
$21K ﹤0.01%
20,130
ATHX
1647
DELISTED
Athersys, Inc. Common Stock
ATHX
$21K ﹤0.01%
560
-440
-44% -$19.4K
HHS icon
1648
Harte-Hanks
HHS
$18.5M
$18K ﹤0.01%
1,200
NAVB
1649
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$18K ﹤0.01%
1,388
+200
+17% +$3.17K
ORIG
1650
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$18K ﹤0.01%
1

Similar funds

Cambridge Investment Research Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Cambridge Investment Research Advisors held 1,883 positions worth $5.34B, down 0.95% from $5.39B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q4 2016 filing shows 141 new, 840 increased, 630 reduced and 218 closed positions. Its largest new stake was Walt Disney: 210,502 shares worth $21.9M. The largest sale was Apple, an estimated $96.5M.

By sector, the portfolio is most concentrated in Industrials at 4.4% of assets, up from 4.3% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2016 buy was Walt Disney: 210,502 shares worth $21.9M.
  • Cambridge Investment Research Advisors added most to First Trust Horizon Managed Volatility Domestic ETF in Q4 2016, an estimated $41.6M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2016 reduction was First Trust Large Cap Core AlphaDEX Fund, cutting an estimated $30.1M.
  • Cambridge Investment Research Advisors fully exited Apple in Q4 2016, selling an estimated $96.5M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $5.34B portfolio in Q4 2016.
  • Cambridge Investment Research Advisors opened 141 new positions and closed 218 in Q4 2016.
  • Cambridge Investment Research Advisors's portfolio value fell 0.95% quarter-over-quarter to $5.34B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.